Harvard Bioscience develops, manufactures and sells technologies and services that enable advances in life science research, drug discovery, therapy development and preclinical testing. The company serves academic institutions, government laboratories, pharmaceutical and biotechnology companies, and contract research organizations through two main product families: Cellular and Molecular Technology (including electroporation instruments, amino acid analyzers, electrophysiology systems and organoid research tools) and Preclinical (including telemetry systems, behavioral monitoring and respiratory systems). Revenue derives from both direct sales to end-users and distribution channels, with the company targeting expansion of higher-margin consumables and software toward recurring revenue models.